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A B S T R A C T
Background and introduction: Low and middle-income countries (LMIC) have a considerable burden of neuro-
logical disorders. Available profile of neurological disorders in our environment is biased towards neurological
admissions. There is a paucity of data on out-patient neurological conditions in sub-Saharan Africa.
Objective: To determine the frequency and demographic data of neurological illnesses being managed at the
adult out-patient neurology clinic of the Aga Khan Hospital, Dar es Salaam (AKHD).
Materials and methods: The electronic medical records of all cases with neurological diseases who presented to
the adult neurology clinic of the AKHD between January 2018, and December 2019 were retrospectively re-
viewed and analyzed. Neurological disorders are categorized according to the international classification of
diseases version-11(ICD-11).
Results: Of the 1186 patients seen in a period of 2 years, there were 597 (50.4%) females and 588(49.6%) males,
with median age (IQR) of 38 (30.0–52.0) and 42 (33.0–54.5) years respectively (p= 0.001). Headache disorders
(27.0%); disorders of the nerve root, plexus or peripheral nerves (23.4%); epilepsy (9.3%), cerebrovascular
disorders (8.9%); movement disorders (3.6%) and disorders of cognition (3.5%) were the primary neurological
conditions encountered. Musculoskeletal disorders (7.5%) and mental/behavioral disorders (5.4%) were other
conditions seen in the clinic.
Conclusion: The pattern of neurological disorders in this cohort mirrors that of high-income countries. However,
the manpower to tackle these conditions pales in comparison. Increasing the neurology workforce and paying
extra attention to non-communicable disorders in SSA is advocated.
1. Introduction
Neurological disorders account for more than 6% of the global
burden of diseases. More than 1% of all deaths and 28% of all disability-
adjusted life years (DALY) is due to neurological disorders [1]. Low and
middle-income countries (LMIC) bear the greater proportion of this
burden [2],. This trend is on the increase [3] due to several factors such
as improvement in maternal and child health, increasing age of popu-
lations, and newly recognized disorders of the nervous system [1]. As a
result, the global prevalence of neurological disorders is projected to hit
14.7% by 2020 [1]. Ironically, neurological manpower is far from being
adequate to manage the present burden, as well as the projected up-
surge. With an average of 0.04 neurologists per 100,000 populations in
Africa, there is a staggering inadequacy of skilled professionals to ef-
fectively tackle the wide spectrum of neurological diseases, and provide
timely and efficient preventive, restorative and rehabilitative services
[4].
The burden of disease analyses is useful for informing health policy.
It helps in identifying not only the fatal but also the non-fatal outcomes
for diseases generally and of neurological illnesses in particular.
Empirical evidence in our environment shows that the demand for
neurological services is increasing. The quest for rapid, quality and
evidenced based therapeutic measures in addition to increasing health
literacy seems to drive this pursuit [5]. Although in-patient and com-
munity pattern of neurological diorders in some regions of Tanzania
have been previously descibed [6,7], there is pacuity of data on out-
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T
patient spectrum of neurological diorders.Characterizing consultation
pattern can reveal the uptake rate of available neurological services.
Furthermore, it can enhance the evaluation of individualized therapy;
promote appraisal of quality of care, [8] and provide data for
strengthening neurology manpower, delivery and expansion of services
[9].
This study aims to determine the spectrum of neurological disorders
presenting to the adult neurology clinic of AKHD, Tanzania. The study
also aims to determine the demographic distribution of the main sub-
categories of the neurological conditions.
2. Methods
This study was a 2 years retrospective survey of out-patient adult
neurological consultations at the AKHD, Tanzania. Dar es Salaam is the
economic capital of Tanzania and boasts of a population of 4,364,541,
according to the official 2012 census [10]. It lies on latitude 6° 48′ 0″ S,
and longitude 39° 17′ 0″ E. Dar es Salaam is one of the fastest-growing
cities in the world and attracts a multi-ethnic group of residents. The
AKHD, a joint commission international accredited (JCIA) private not
for profit institution of health, is one of the oldest private health es-
tablishments in the metropolis which provides multidisciplinary sec-
ondary and tertiary care to the population. It is a 150 bedded institution
that also serves as the teaching facility for the nascent faculty of post-
graduate medical education of the Aga Khan University (AKU), Dar es
Salaam, Tanzania. The AKHD offers a continuum of care that is co-
ordinated across its primary medical centres (PMCs) in the urban areas
of Mbeya, Iringa, Dodoma, Morogoro, and Mwanza and the 18 outreach
health centers (OHCs) in Tanzania with 12 0f them being in Dar es
Salaam.
The neurology unit of the hospital provides both in-patient and out-
patient neurological services to residents of Dar es Salaam and other
regions of Tanzania. The neurology unit is supported by a new clinical
neurophysiology laboratory established in 2017. The laboratory per-
forms electroencephalography (EEG) - including prolonged and video
EEGs, evoked potential studies (EPs), electrodiagnostic (EDx) studies
and sleep studies (the sleep laboratory was established in 2019).
Radiological support is provided by the radiology department (Headed
by AJ) that is equipped with a 1.5Tesla magnetic resonance imaging
(MRI) machine, a computerized tomography (CT) scan machine as well
as ultrasound machines for vascular and nerve ultrasonography.
The cardiology unit and the pathology departments provide addi-
tional supports for diagnostic evaluation of patients. Genetic screening
and autoantibodies assay are outsourced. We do not perform nerve
biopsies. The neurology clinic is staffed with 1 full time neurologist
(PBA) who had fellowship training in clinical neurophysiology. The in-
house neurologist is supported by a visiting adult neurologist (EA) and
another visiting pediatric neurologist. There is a neurosurgeon (MCM)
in the hospital who is also supported by another visiting surgeon. The
final neurological diagnoses were arrived at, based on the patient's
primary presentation, neurological exam, and subsequent blood, cere-
brospinal fluid (CSF), radiological, and/or neurophysiological studies.
The scientific committee as well as the health research and ethics
committee of AKHD and AKU Tanzania approved the study.
2.1. Data collection
A 2 year medical records (January 1, 2018 to December 31, 2019) of
all adult neurology clinic consultations at the AKHD was collected from
the health information and statistics (HIS) departments of the hospital.
The HIS department operates an electronic medical record therefore; it
is easier to trace all new and follow up consultations. Additional records
were sought from other departments such as the radiology, cardiac,
pathology and neurophysiology units, if clinical consultations were
insufficient. The extracted data were patient's age, gender, date of
consultation, diagnosis, medications and other adjuvant therapies.
2.2. Categorization
The identified cases were classified according to the international
classifications of diseases version 11 (ICD11) and cases confirmed as
neurological were further analyzed. We have chosen to use ICD11
classification since the WHO website has officially approved six ICD-11
linearization [11] of which neurology is one. According to the ICD11
classification, neurological cases are classified as follows [1] movement
disorders, [2] disorders with neurocognitive impairment as a major
feature, [3] multiple sclerosis or other white matter disorders, [4]
epilepsy or seizures, [5] headache disorders, [6] cerebrovascular dis-
eases, (7)spinal cord disorders excluding trauma, [8] motor neuron
diseases or related disorders, [9] disorders of nerve root, plexus and
peripheral nerves, [10] diseases of neuromuscular junction or muscles
[11], cerebral palsy, [12] nutritional or toxic disorders of the nervous
system, [13] diseases of cerebrospinal fluid pressure or flow, [14] dis-
orders of autonomic nervous system, [15] human prion diseases, [16]
disorders of consciousness, [17] other disorders of the nervous system
and, [18] post procedural disorders of the nervous system.
2.3. Statistical analysis
Descriptive statistics was performed to determine the frequency of
neurological disorders as well as gender and age distribution.
Continuous variables were summarized as means (standard deviation)
when data was normally distributed. Skewed data were summarized as
median (interquartile range, IQR). Pearson chi square test was used to
determine between group differences of categorical data. Means and
medians were compared using either the student's t-test or
Mann–Whitney's U test for paired comparisons. All statistical analyses
were performed using SPSS version 22.0 (SPSS, Chicago, Illinois). A P-
value< 0.05 was considered to be statistically significant.
3. Results
3.1. Demography and frequency of classes of neurological disorders
One thousand, one hundred and eighty-six (1186) patients were
seen during the period, with an overall median age (IQR) of 40
(32.0–53.0) years. There were 597 (50.4%) females and 588 (49.6%)
males with median age (IQR) of 38 (30.0–52.0) and 42 (33.0–54.5)
years respectively (p = 0.001). Table 1 shows the age distribution of
the patients according to gender. Females within the age of 21–30 years
were significantly more than males (p = 0.004), while males between
the ages of 71–80 years were significantly more than females
(p = 0.003). Table 2 shows the categories of neurological disorders
according to ICD 11 Classification. During the period under review, we
did not see disorders of [1] autonomic nervous system, [2] Human
Prion diseases, and disorders of consciousness; hence, these disorders
did not reflect on Table 2. Other conditions not categorized under
section 8 of ICD 11 classifications were included as disorders classified
elsewhere.
3.2. Headache disorders
Three hundred and twenty patients (27.0%) consulted the clinic for
headache disorders. The mean age ± SD was 36.27 ± 12.27. There
was no difference in age between the genders (p = 0.958). Migraine
(54.2%), followed by tension type headache (18.1%), were the pre-
dominant primary headaches. Thirteen (4.0%) patients had chronic
daily headache while 10 patients (3.1%) had trigeminal autonomic
cephalagias (cluster headache, 6 (0.5%); paroxysmal hemicranias,
3(0.25%); cluster tic syndrome = 1 (0.008%). Table 3 shows the other
types of headaches. Females were the predominant sufferer of headache
disorders (p ≤0.001). Fig. 1 shows age and gender distribution of
headache disorders in this study. The modal age distribution for both
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genders was 31–40 years.
3.3. Disorders of nerve root, plexus, and peripheral nerves
Of the 278 patients with mean ± SD of 46.15 ± 13.26 years
belonging to this category, 154 (55.4%) had cervical, lumbar spondy-
lotic radiculopathy or polyradiculopathy. Seventy-nine patients had
mononeuropathy, while 43 patients had polyneuropathy, constituting
28.4% and 15.5%, respectively. There was no significant gender dif-
ference in this category (p = 0.401). Fig. 4. shows the age and gender
distribution of the patients in this group. The females in this category
had two modal age range; 31-40 years and 41–40 years. The modal age
range for males was 41–50 years. Detailed diagnosis of the mono-
neuropathy and polyneuropathy subgroup is presented in Table 3.
3.4. Epilepsy and seizures
Of the 111 patients in this group, 50 (45%) had epilepsy due to
structural or metabolic conditions while 52(46.8%) had genetic/ pre-
sumed genetic epilepsy. Four patients (3.6%) had epileptic encephalo-
pathy while 3 (2.7%) patients had seizures due to acute causes. Two
cases (1.8%) of unprovoked seizures were seen. The median age (IQR)
of patients in this group was 33.0 (20.0–49.0). There was no gender
difference between males and females (p= 0.626). Fig. 2 shows the age
and gender distribution of epilepsy and seizure disorders. The modal
age range of females was< 20 years, while males had a modal age
range of 31–40 years.
3.5. Cerebrovascular disease
One hundred and six (8.9%) patients with median age (IQR) of 57.0
(49.5–69.0), had cerebrovascular diseases. There was no gender no age
difference between the genders (p = 0.782). All the patients had brain
imaging (CT and/or MRI) as well as vascular imaging (CT angiography
or MR angiography) hence, adjudication of stroke types, arterial terri-
tory, and aetiology was possible for all cases. Ischaemic stroke pre-
dominated this group at 91.5%. Intracranial haemorrhage (in-
tracerebral and subarachnoid haemorrhage) was the diagnosis in 6.6%
patient. There were 2(1.9%) cases of transient ischaemic attacks (TIA).
Although a preponderance of male ischaemic stroke survivors was
noted, there was no significant difference between the genders
(p = 0.21). Fig. 3 shows the age and gender distribution of patients
with cerebrovascular disorders. The modal age range for both sexes was
51–60 years.
3.6. Movement disorders
Forty-three cases (3.6%), with median age (IQR) of 52. 50
(34.0–65.75) had movement disorders. There was no difference in age
between the genders (p = 1.0). Dystonia and Parkinson's disease were
the most common conditions in this group at 27.9% and 16.3%,
respectively. The median (IQR) of patients with Parkinsonian disorder
was 62 (49–73), while that of the dystonia group was 40 (29–54.5).
Focal and segmental dystonia made up more than 90% of the cohort
with dystonia. There was no gender difference in this group
(p = 0.259). Table 3 shows more detailed diagnoses of the other sub-
categories in this group.
3.7. Disorders with neurocognitive impairment as a major feature
Forty-one patients (3.5%) had neurocognitive disorders and vas-
cular dementia was the most common condition in this category
(43.9%). Alzheimer's disease (AD) was the next most common (31.7).
The mean age (SD) of this cohort is 66.4(15.3), with an age range of
30–82. There was a significant gender difference in this category
(p = 0.018); more females had Alzheimer's disease while more males
had vascular dementia. There were 5 (12.2%) patients who had
Dementia with lewy bodies (DLB) and 2 patients (4.9%) with normal
pressure hydrocephalus. Mild cognitive impairment (MCI) was present
in 3 (7.3%) patients.
3.8. Disease of neuromuscular junction or muscles
Nine patients (0.75%) belonged to this category. With 8 patients
(0.67%) diagnosed with myasthenia gravis and 1(0.08%) case of
Duchene muscular dystrophy. The median (IQR) of the patients with
myasthenia gravis was 41.0(34.7–45.0) with a female: male ratio of 1:1.
Of the myasthenia gravis cases, 2 were ocular myasthenia and 6 were
generalized. The patient thought to be having Duchene muscular dys-
trophy declined genetic testing. However, his phenotypic features are
no doubt in keeping with the disorder.
3.9. Multiple sclerosis (MS) and other white matter disorders
Four patients with mean age ± SD of 26.0 ± 8.41 belonged to this
category. The male to female ratio in this category was 3:1. Two
(0.17%) had MS (0.34%) and one (0.08) had a clinically isolated syn-
drome. These were all females. The male patient had neurosarcoidosis.
This case was diagnosed from an outside facility. The patient was being
followed up in our facility.
3.10. Other neurological conditions
As shown in Table 2, other less frequent disorders included spinal
cord disorders excluding trauma (0.3%), motor neuron diseases or re-
lated disorders (0.3%) and nutritional or toxic disorders of the nervous
system (0.25%), disorders of cerebrospinal fluid pressure or flow (0.16)
and post procedural disorders of the nervous system (0.16%).There was
a case of spastic cerebral palsy (0.08%).
Table 1
Age and gender distribution of the patients
Age distribution Total Males Females X2 OR 95% CI P value
1,186 (100%) 588 (100%) 597 (100%)
< 20 years 96 (8.1) 42 (7.1) 54 (9.0) 1.46 1.29 0.85–1.97 0.227
21–30 years 157 (13.2) 61 (10.4) 96 (16.1) 8.46 1.66 1.18–2.34 0.004*
31–40 years 352 (29.7) 168 (28.6) 184 (30.8) 0.75 1.12 0.87–1.43 0.386
41–50 years 235 (19.8) 132 (22.4) 103 (17.3) 4.96 0.72 0.54–0.96 0.026*
51–60 years 171 (14.4) 85 (14.5) 86 (14.4) 0.00 0.99 0.72–1.38 0.990
61–70 years 84 (7.1) 42 (7.1) 42 (7.0) 0.00 0.99 0.63–1.54 0.949
71–80 years 67 (5.7) 45 (7.7) 22 (3.7) 8.70 0.46 0.27–0.78 0.003*
> 81 years 23 (1.9) 13 (2.2) 10 (1.7) 0.74 0.70 0.31–1.59 0.391
X2 = Pearson chi square; OR = odd ratio; * = significant value.
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Table 2
Neurological Disorders according to ICD 11 Classification.
ICD 11 classifications Frequency Neurological disorders Male Female P value
n (%) n (%) n (%) n (%)
Movement disorders 43(3.6) Parkinson’s disease 5 (19.2) 2 (11.8) 0.259
Parkinson’s plus syndrome 3 (11.5) 1 (5.9)
Drug induced Parkinsonism 3 (11.5) 0 (0.0)
Essential tremor 1 (3.8) 4 (23.5)
Other tremors 1 (3.8) 3 (17.6)
Dystonia 8 (30.1) 4 (23.5)
Others 5 (19.2) 3 (17.6)
Total 26 (100) 17 (100)
Disorders with neurocognitive impairment as a major feature 41 (3.5) Alzheimer’s disease 3 (15.0) 10 (47.6) 0.018*
Vascular dementia 12 (60.0) 6 (28.6)
Dementia with lewy bodies 3 (15) 2 (9.5)
Normal pressure hydrocephalus 2 (10.0) –
Mild cognitive impairment, no dementia 0 (0.0) 3(14.3)
Total 20 (100) 21(100)
Multiple sclerosis and other white matter disorders 4 (0.3) Neurosarcoidosis 1 (100) – -
Multiple sclerosis – 2 (66.6)
Clinically isolated syndrome – 1 (33.3)
Total 1 (100) 3 (100)
Epilepsy or seizures 111(9.3) Epilepsy due to structural or metabolic condition 26 (48.1) 24 (42.1) 0.545
Genetic or presumed genetic condition 25 (46.3) 27 (47.4)
Epileptic Encephalopathy 2 (3.7) 2 (3.5)
Seizure due to acute causes 0 3 (5.3)
Single unprovoked seizures 1 (1.9) 1 (1.8)
Total 54 (100) 57 (100)
Headache disorders 320 (27.0) Migraine 54 (42.9) 120 (61.9) < 0.001*
Tension type headache 18 (14.3) 40(20.6)
Chronic daily headache 7 (5.6) 6(3.1)
Trigeminal autonomic celphalagias 6 (4.8) 4(2.1)
Cervicogenic headaches 20 (15.9) 19(9.8)
Others 21 (16.7) 5(2.6)
Total 126 (100) 194(100)
Cerebrovascular disease 106 (8.9) Ischaemic stroke 63 (87.5) 34(100) 0.210
Haemorrhagic stroke 6 (8.3) -
Subarachnoid haemorrhage 1 (1.4) -
Transient ischaemic attack 2 (2.8) -
Total 72 (100) 34 (100)
Spinal cord disorders excluding trauma 4 (0.3) Potts disease 1 (50) 0.306
HTLV associated myelopathy 1(50) –
Compressive myelopathy from prolapsed disc 1(50) –
Transverse myelitis 1 (50)
Total 2(100) 2 (100)
Motor neuron diseases or related disorders 4 (0.3) Amyotrophic lateral sclerosis 2(100) 1 (50) 0.248
HIV associated motor neuron disease – 1 (50)
Total 2 (100) 2 (100)
Disorders of nerve root, plexus or peripheral nerves 278 (23.4) Cervical radiculopathy 41 (27.0) 29 (23.0) 0.401
Lumbar radiculopathy 40 (26.3) 38 (30.2)
Cervical & lumbar polyradiculopathy 2 (1.3) 4 (3.2)
Brachial plexopathy 2 (1.3) -
Mononeuropathy 40 (26.3) 39 (31.0)
Polyneuropathy 27 (17.8) 16 (12.7)
Total 152 (100) 126 (100)
Disease of neuromuscular junction or muscles 9(0.75) Myasthenia gravis 3 (75.0) 5 (100) 0.236
Duchene muscular dystrophy 1 (25.0) –
Total 3 (100) 5 (100)
Cerebral palsy 1 (0.08) – 1 (100) –
Nutritional or toxic disorders of the nervous system 3 (0.25) Alcohol withdraw syndrome 1 (50.0) – 0.223
Korsakoff syndrome 1 (50.0) –
Vitamin B 12 deficiency – 1(100)
Total 3 (100) 1(100)
Disorders of cerebrospinal fluid pressure or flow 2(0.16) Idiopathic intracranial hypertension – 1(100)
Arachnoid cyst 1(100) –
Total 1 (100) 1 (100)
Post procedural disorders of the nervous system 2 (0.16) Post dura puncture headache – 2 (100) –
(continued on next page)
P.B. Adebayo, et al. eNeurologicalSci 20 (2020) 100262
4
3.11. Other conditions classified elsewhere
Aside from the core neurological disorders detailed above, other
illnesses that were commonly encountered in the clinic are as sum-
marized in Table 2. Musculoskeletal diseases were quite prevalent in
this group, as it accounted for 7.6% of cases. These cases mostly consist
of cervical and lumbar sprain and/or spasm. The next most common
group of conditions is disorders of mental, behavioral and neurodeve-
lopmental disorders. Among this cohort, anxiety and fear related dis-
orders made up 2.9%, followed by dissociative neurological symptom
disorders (functional neurological disorders) at 1.7%. Other painful
conditions made up 2.1%, while disorders of vestibular function con-
stituted 2.0%. Sleep and wake disorders (0.7%), CNS tumor (0.5%), and
CNS infections (0.7%) were other conditions encountered in this group.
4. Discussion
This study has profiled the spectrum of out-patient neurological
disorders encountered in an adult neurology clinic of a private aca-
demic hospital in Tanzania. In this cohort of 1186 patients, we noted
that headache disorders; disorders of the nerve root, plexus and per-
ipheral nerves, epilepsy and cerebrovascular diseases were the pre-
dominant illnesses for which neurological consultations were sought.
These four groups of disorders accounted for close to 70% of all the
cases. This pattern is not in contrast to what is obtainable in out-patient
neurology clinics in high-income countries (HIC). In Europe, headache,
epilepsy, functional or psychological disorders, neuromuscular and
peripheral nerve disorders as well as MS and related diseases are the
predominant out-patient neurological cases [12,13,14].
In Africa, Siddiqi et al. in Zambia, found that the pattern of out-
patient neurological conditions was similar to what might be expected
in HIC [15] and Tegueu et al. in Cameroun [16] noted the same. Extant
literatures show that CNS infectious diseases, cerebrovascular disorders
and epilepsy including febrile convulsions were dominant neurological
diagnoses in sub-Saharan African; including previous studies from
Tanzania [17,18,19,6,20]. It should be noted, however, that these
studies were conducted majorly among in-patient admissions hence;,
our comparison is somewhat cautious because acute neurological cases
like stroke and CNS infections are more likely to be admission cases
[15].. The above being said, our study almost mirrors the pattern in the
community when compared to the prevalence study by Dewhurst et al.
[7] among older people in northern Tanzania. Aside for the dominance
of movement disorders in that survey; headache, neuropathies and
stroke constituted the bulk of other neurological diseases. In contrast to
our study, Sarfo et [2] in Ghana found stroke to be the principal out-
patient neurological diagnosis, followed by epilepsy and movement
disorders. Variation in the service organization, referral bias, and the
type of health facilities (government vs. private) could be responsible
for the dissimilarities, although this assumption could be termed a
priori. Ours, being a private health institution, patients can request for
Table 2 (continued)
ICD 11 classifications Frequency Neurological disorders Male Female P value
n (%) n (%) n (%) n (%)
Other conditions classified elsewhere 258 (21.7) 0.265
Mental, behavioural or neurodevelopmental disorders 58 (4.9) Anxiety and fear related disorders 17 (13.8) 16 (11.8)
Functional neurological disorders 10 (8.1) 10 (7.4)
Neurodevelopmental disorders 3 (2.4) 2 (1.5)
Musculoskeletal disorders 90 (7.5) Cervical and lumbar sprain and/or spasm 40 (32.5) 50 (37.0)
Central nervous system (CNS) tumor 6 (0.05) Meningioma, schwannoma, pituitary adenoma 4 (3.2) 2 (1.5)
Central nervous system (CNS) infections 9 (0.7) TB meningitis and Cryptococci meningitis 1 (0.8) 8 (5.9)
Disorders of vestibular function 24 (2.0) Benign positional vertigo and Meniere’s disease 14 (11.3) 10 (7.4)
Sleep and wake disorders 9(0.7) Insomnia, sleep apnea & restless leg syndrome 7 (5.7) 2 (1.5)
Fibromyalgia 15(1.3) – 6 (4.9) 9 (6.6)
Other painful conditions unspecified 25 (2.1) – 11 (8.9) 14 (10.3)
General medical conditions 22(1.8) – 10 (8.1) 12 (8.9)
Total 123 (100) 135 (100)
Total 1186 (100)
Table 3
More detailed diagnoses not reflected on Table 2
ICD 11 (n = frequency) Diagnosis (n)
Movement disorders
Parkinson’s Plus syndrome (n = 4) Vascular parkinsonism (1), progressive supranuclear palsy (2),multiple system atrophy (1)
Dystonia (n = 12) Hemifacial spasm (5),Meige syndrome (1),cervical dystonia (2),tardive dyskinesia (2), writer’s cramp (1),generalized
dystonia (1)
Others (n = 8) Hereditary ataxia (1),myoclonus(3),Tremor-dystonia (1),suspected SCA (3)
Disorders with neurocognitive impairment as a major
feature
Others (n = 3) Mild cognitive impairment, no dementia.
Headache
Trigeminal autonomic celphalagias Cluster headache (6), paroxysmal hemicranias(3), cluster –tic syndrome (1)
Other headaches Medication overuse headache(1),nummular headache (1),sinus headache (7), post traumatic headache (12),primary
stabbing headache (1),hypnic headache (1),TMJ subluxation (1), unclassified (2)
Nerve root, plexus and nerves
Mononeuropathy (n = 84)a Bell’s palsy(16), trigeminal neuralgia(18), numb cheek syndrome(1), optic neuropathy (1), peripheral Horner’s
syndrome (2) Intercostal neuralgia (4), carpal tunnel syndrome(15), ulnar neuropathy(16), radial neuropathy (2),
femoral neuropathy (1), peroneal neuropathy(3),piriformis syndrome (1), sciatic neuropathy (1).
Polyneuropathy (n = 43) Guillain Barré syndrome (4), CIDP (1), sensory polyneuropathy (30), sensory-motor polyneuropathy(3), small fiber
neuropathy(5)
a 5 patients had concurrent ulnar neuropathy and carpal tunnel syndrome hence the higher frequency of mononeuropathy; GBS, Guillain–Barré syndrome; CIDP,
Chronic inflammatory demyelinating polyneuropathy; SCA, spinocerebellar degeneration; TMJ, temporomandibular joint subluxation.
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Fig. 1. Age and Gender distribution for Headache disorders.
Fig. 2. Age and gender distribution for Epilepsy and Seizures.
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Fig. 3. Age and gender distribution for cerebrovascular diseases.
Fig. 4. Age and gender distribution for disorders of nerve roots, plexus and peripheral nerves.
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neurological consultations without a referral from a primary care
physician or other medical specialties.
Headache is the most frequent neurological diagnosis in this cohort.
This finding is similar to patterns in other studies in HIC [12,13,14] and
SSA [16].. The high proportion of headache disorders in our group may
not be unrelated to the high prevalence of the major primary headache
disorders in Tanzania [21,22,23,24]. Migraine, Tension-type headache
(TTH) and medication overuse headache (MOH) are the 3 headache
disorders of public health importance but migraine is the most dis-
abling. Migraine is the second cause of disability globally [25]. It is the
first cause of disability in people below 50 years [26]. Migraine affects
one in ten people worldwide indicating a recent rise [27]. and higher
prevalence is found among females, students, and urban residents just
like our study suggests [28]. Although efforts at lifting the burden of
headache are being instituted and recognized on the global level [ 29],
similar efforts are not visible in LMIC, especially Africa. Advocacy work
to mitigate the burden of headache disorders is hugely needed and it is
recommended that these endeavors should be championed by patients
and practitioners [29].
The global burden of stroke has been well described [30]. Within
the combined burden of neurological disorders, cerebrovascular dis-
eases as measured in the GBD 2010, contribute an enormous propor-
tions of DALY [3] Among in-patients in sub-Saharan Africa, stroke is the
leading cause of neurological admission [6,31,32]. However, in this
out-patient cohort, it is the fourth most common condition; in agree-
ment with other studies [15,16] This pattern would not be said to re-
flect the prevalence of stroke in the community as Dar es Salaam has
been known to have a high incidence of stroke [33]. The rising burden
of stroke in Tanzania is well documented [34], our institution is stroke
ready and has an approved stroke fast pathway for triaging acute stroke
cases in the emergency room. Patients who qualified for intravenous
thrombolysis are offered the service. Mechanical thrombectomy pro-
gram is yet to begin. Cases of cerebral haemorrhage requiring surgical
intervention are managed, discharged and followed up by the neuro-
surgical team. This could account for the low frequency of haemor-
rhagic stroke in our cohort. Although Sarfo et al. reported a higher
proportion stroke in their out-patient facility, the modal age range of
cerebrovascular disease in our study mirrors that in Kumasi [2]. The
demographic, nutritional and epidemiological transition that is hap-
pening across LMIC is undoubtedly driving the incidence of cardio-
vascular risk such as metabolic syndrome, hypertension and diabetes.
Staunching this trend with proven preventive measures is indeed ob-
ligatory.
Over 85% of people living with epilepsy are found in low- and
middle-income countries, including sub-Saharan Africa [35]. Epilepsy
accounted for 9.3% of all the cases seen during this period. This pro-
portion is similar to the studies [2,15,16]. The aetiology of epilepsy in
Africa has been well described [36]. In this cohort of patients with
epilepsy secondary to structural or metabolic brain disorders, we found
that stroke, CNS trauma, mesial temporal sclerosis, and atrophy/neu-
rodegenerative disorders were responsible for most cases in the cate-
gory. Aside infections, non –communicable diseases play a corre-
sponding and significant role in the onset of epilepsy in SSA. This
underscores the need to increase public awareness of preventive mea-
sures against conditions such as traumatic brain injury, stroke and de-
mentia. Stoke advocacy and public education would need to be esca-
lated as well. Stroke survivors are significantly at a high risk of seizures
[37] hence prevention is key. In the same manner, perinatal issues need
to be well communicated and emphasized to the public.
Parkinsonian disorders and dystonia are the leading movement
disorders in this cohort. As already established, the Parkinsonian dis-
orders are common in the elderly. We saw two patients with early-onset
Parkinson's disease, but further exploration of genetic underpinning
could not be performed. The dystonia group was younger, though focal
dystonia; Hemifacial spasm in particular was the dominant type in this
cohort. In larger neurology practice, cervical dystonia is the most
frequent focal dystonia [38]. The effort by the MDS to improve the
diagnosis and management, including training and education of
healthcare workers, is yielding fruits in Africa [39]. The frequency of
disorders of cognition was comparable to that of movement disorders in
our study and Alzheimer's disease trailed vascular dementia in rate. The
dominance of the female gender with AD in this cohort reflects the
already established pattern. About two-thirds of patients with AD are
women [40]. Sex and gender differences in risk factors, symptom pre-
sentation, mortality and treatment are significant contributors to this
pattern. A focus on these differences will lead to improved care and
treatment [41].
Disorders of the peripheral nerves form a substantial proportion of
patients in our study, and it is similar to the survey by stone et al. [12]
We have gone ahead to detail the spectrum of these disorders (Table 3)
and narrow down the diagnosis with electrophysiological data when
available. The lead author's subspecialty interest is in the area of per-
ipheral nerve disorders, and this bias could have influenced referrals.
Vestibular disorders and mental health disorders, in particular, func-
tional neurological disorders, are encountered frequently by neurolo-
gists. Our data supports this. Recent insights from brain imaging and
neurophysiology studies are helping to differentiate functional and
feigned symptoms. Although these patients would benefit from both
psychiatrist and neurologist review, the pendulum is again swinging in
the direction of neurologists as the physician to take responsibility for
functional neurological disorders [42].
4.1. Study limitations
Its retrospective observational single center design limits our study.
Undoubtedly, the findings would not represent the pattern of neurolo-
gical disorders in the general population. Furthermore, this study po-
pulation is highly selective, consisting of middle and high-income
earners who have good insurance coverage or can pay cash for their
healthcare costs. The strength of our study lies however, in the ability to
thoroughly investigate our patients aside from other clinical evalua-
tions as neurology demands. The electronic record system also ensured
complete data capturing. Certainly, diagnostic confidence and accuracy
is high in this cohort.
5. Conclusion
In this cohort of urban dwellers who accessed care in a private
academic hospital, we noted that non-communicable diseases of
headache, peripheral nervous disorders, epilepsy and stroke were the
leading cause of neurological consultation. Efforts at mitigating the
burden of these illnesses at the population level might stem the raging
tide of non-communicable neurological disorders in our environment.
Future expansion of neurology services should explore establishment of
specialty clinics devout to specific conditions such as headache, neu-
romuscular, epilepsy and stroke.
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